CHRONIC URTICARIA
Clinical trials for CHRONIC URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hive drug shows promise in Head-to-Head trial against XOLAIR
Disease control CompletedThis study tested whether a new medicine, TEV-45779, works as well as the approved drug XOLAIR for people with chronic hives (itchy welts) that don't get better with standard allergy pills. About 608 adults took part. The main goal was to see how much itching improved after 12 we…
Matched conditions: CHRONIC URTICARIA
Phase: PHASE3 • Sponsor: Teva Pharmaceuticals USA • Aim: Disease control
Last updated May 17, 2026 05:29 UTC
-
Real-World study reveals omalizumab dosing patterns for chronic hives in china
Knowledge-focused CompletedThis study examined how the drug omalizumab is prescribed to adults with chronic urticaria (long-term hives) in China. Researchers analyzed electronic health records from 3,485 patients to see which doses were most common. The goal was to understand real-world treatment patterns,…
Matched conditions: CHRONIC URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 12, 2026 13:44 UTC